Election 2026

The November 3 election will reshape legislatures. Stay current on every seat, staff, and committee change with GovBuddy.

Stay Current
Home/Bills/S 1813New York · 2025–2026 Legislative Session
Senate BillIntroduced

S 1813: Relates to medical assistance for patients in the process of oral or injectable ovulation enhancing drugs.

New York · Senate · 2025–2026 Legislative Session · last verified January 9, 2026

What S 1813 does, verified January 9, 2026

The proposed law aims to provide medical assistance for patients undergoing oral or injectable ovulation enhancing drugs. It includes coverage for a set of services to improve treatment outcomes, such as office visits, hysterosalpingogram services, pelvic ultrasounds, and blood testing. These services are limited to those necessary to monitor treatment. In the event that federal funding is not available, the state will use its share of appropriations to fund a grant program to achieve the law's purpose. The law will take effect 90 days after it becomes a law.

Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: REFERRED TO HEALTH (2026-01-07)Alert me
Recent actions2 total · showing 2
Jan. 07, 2026REFERRED TO HEALTH
Jan. 14, 2025REFERRED TO HEALTH
Latest bill textIntroduced version, January 14, 2025 · 274 words
  
  STATE OF NEW YORK ________________________________________________________________________ 1813 2025-2026 Regular Sessions  IN SENATE January 14, 2025 ___________ Introduced by Sens. FERNANDEZ, FELDER -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the social services law, in relation to medical assist- ance for patients in the process of oral or injectable ovulation enhancing drugs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (ee) of subdivision 2 of section 365-a of the 2 social services law, as added by section 4 of part S of chapter 57 of 3 the laws of 2017, is amended to read as follows: 4 (ee) Medical assistance shall include the coverage of a set of 5 services to ensure improved outcomes of [women] patients who are in the 6 process of oral or injectable ovulation enhancing drugs, limited to the 7 provision of such treatment, office visits, hysterosalpingogram 8 services, pelvic ultrasounds, and blood testing; services shall be 9 limited to those necessary to monitor such treatment. In the event that 10 ninety percent federal financial participation for such services is not 11 available, the state share of appropriations related to these services 12 shall be used for a grant program intended to accomplish the purpose of 13 this section. 14 § 2. This act shall take effect on the ninetieth day after it shall 15 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05352-01-5 
Text of S 1813 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions
GovBuddy Demo

See how GovBuddy fits your team.

Share a few details and our team will follow up with a focused walkthrough.